Supplies of bladder cancer drug are dwindling
(By Alia Paavola for Becker’s Hospital Review) Supplies of BCG, a critical immunotherapy drug that treats bladder cancer, are dwindling,
Read moreDrug spending could rise 6.1 percent annually by 2020, federal projections show
(By Ike Swetlitz for STAT) WASHINGTON — Spending on prescription drugs is expected to increase at an accelerating rate over
Read moreMore States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
(By Barbara Feder Ostrov for California Healthline produced by Kaiser Health News) In a growing number of states, patients who
Read moreNational healthcare groups urge Congress to delay Medicaid disproportionate share hospital cuts
(By Kelly Gooch for Becker’s Hospital Review) The American Hospital Association, along with seven other national healthcare organizations, are calling on federal
Read moreCMS can terminate private Medicare plans with poor Star Ratings again
(By Morgan Haefner for Becker’s Hospital Review) CMS informed Medicare Advantage and Part D drug plans that it will begin
Read moreFDA: Young-blood transfusions provide ‘no proven clinical benefit’ for aging, Alzheimer’s
(By Rebecca Robbins for STAT) The quest to rejuvenate aging people with the blood of young donors has generated paying
Read moreMortality rates lower in US counties with more primary care physicians
(By Megan Knowles for Becker’s Hospital Review) Mortality rates are lower in U.S. counties with more primary care physicians than
Read moreWith one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling
(By Meghana Keshavan for STAT) Bob Field was set to kick off his second course of BCG — a potent immunotherapy that
Read moreWalmart drops price of virtual visits from $40 to $4
(By Emily Rappleye for Becker’s Hospital Review) Walmart is offering employees a 90 percent discount on telemedicine, dropping the price
Read more‘Everyone is at fault’: With insulin prices skyrocketing, there’s plenty of blame to go around
(By Nicholas Florko for STAT) WASHINGTON — Fifteen years ago, a patient with diabetes might have paid $175.57 for a
Read more